Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,139.6,mmol/l,2.1,5.1439,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),102233,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.3,mmol/l,1.8,4.4091,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102234,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,139.3,mmol/l,1.6,3.9192,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),102235,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.4,mmol/l,1.4,3.4293,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102236,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.6,mmol/l,2.4,5.8788,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),102241,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.2,mmol/l,2.1,5.1439,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102242,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,139.6,mmol/l,1.9,4.654,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),102243,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.7,mmol/l,2.2,5.3889,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102244,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.8,mmol/l,1.6,3.9192,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days),102249,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),sham surgical control condition (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,139.6,mmol/l,1.4,3.4293,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102250,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,139.8,mmol/l,0.7,1.7146,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days),102251,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),sham surgical control condition (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000785,SR/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.7,mmol/l,0.9,2.2045,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102252,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.3,mmol/l,1.3,3.1843,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days),102253,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),sham surgical control condition (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,141.1,mmol/l,1.8,4.4091,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102254,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,138.9,mmol/l,1.2,2.9394,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days),102255,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days),sham surgical control condition (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.4,mmol/l,1.1,2.6944,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102256,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days)